Ethical Challenges in Conducting Pediatric Homoeopathic Clinical Research: A Narrative Review

Authors

  • Dr. Rakhi Sharma Rajasthan Vidyapeeth Homoeopathic Medical College and Hospital Dabok Udaipur 313001 Author https://orcid.org/0009-0006-2887-2363
  • Dr. Amiya Nanda Dev Goswami Principal, RVHMC, Udaipur, Rajasthan Author
  • Dr. Tanay Vyas Assistant Professor, RVHMC, Udaipur, Rajasthan Author
  • Dr. Neelam Tiwari Assistant Professor, RVHMC, Udaipur, Rajasthan Author

DOI:

https://doi.org/10.67062/jahs.v2.i3.4

Keywords:

Homoeopathy, Pediatric Research, Research Ethics, Informed Consent, Good Clinical Practice, ICMR, Vulnerable Population, Clinical Trials, Child Assent

Abstract

Clinical research involving children is essential for improving pediatric healthcare, but it raises ethical concerns that are different from those encountered in adults. Children have developing cognitive and decision-making abilities and therefore require additional safeguards during research participation. At the same time, excluding children from research can result in inadequate evidence for interventions that are subsequently used in pediatric practice.

These considerations are particularly relevant to homoeopathic clinical research, where individualized prescribing, subjective symptom assessment, treatment modification and the use of individualized medicines can create additional methodological and ethical questions. The present narrative review discusses the major ethical challenges associated with pediatric homoeopathic clinical research, including vulnerability of children, informed consent, child assent, parental permission, risk-benefit assessment, privacy and confidentiality, compensation, ethics committee oversight, research in resource-limited settings and scientific integrity. International frameworks including the Declaration of Helsinki, CIOMS guidelines, ICH Good Clinical Practice and WHO guidance are considered alongside Indian requirements, particularly the ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants and the ICMR National Ethical Guidelines for Biomedical Research Involving Children. The relevance of the 2025 ICMR addendum on Research in Integrative Medicine and the Good Clinical Practice Guidelines for Clinical Trials in homoeopathy is also discussed. Particular attention is given to placebo use, rescue treatment, individualized prescribing, outcome assessment and the need to avoid therapeutic misconception. Ethical pediatric homoeopathic research requires protection of the child's welfare together with adequate scientific rigor, transparency and responsible reporting.

Author Biography

  • Dr. Rakhi Sharma , Rajasthan Vidyapeeth Homoeopathic Medical College and Hospital Dabok Udaipur 313001

    MD scholar 

    PG Department of Paediatrics 

    Rajasthan Vidyapeeth Homoeopathic Medical College and Hospital Dabok Udaipur 313001 

References

1. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human participants. Ferney-Voltaire: World Medical Association; 2024.

2. Council for International Organizations of Medical Sciences. International ethical guidelines for health-related research involving humans. 4th ed. Geneva: CIOMS; 2016. doi:10.56759/rgxl7405.

3. Indian Council of Medical Research. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. New Delhi: Indian Council of Medical Research; 2017.

4. Indian Council of Medical Research. National Ethical Guidelines for Biomedical Research Involving Children. New Delhi: Indian Council of Medical Research; 2017.

5. Indian Council of Medical Research. Handbook on National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. New Delhi: Indian Council of Medical Research; 2018.

6. Indian Council of Medical Research. Ethical Requirements for Research in Integrative Medicine: an addendum to ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017. New Delhi: Indian Council of Medical Research; 2025.

7. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH E6(R3) guideline for good clinical practice. Geneva: ICH; 2025. The current Principles and Annex 1 became effective in the EU on 23 July 2025; Annex 2 was adopted at Step 4 in June 2026 and has a later implementation date.

8. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH E6(R3) guideline for good clinical practice: Annex 2. Geneva: ICH; 2026.

9. World Health Organization. Standards and operational guidance for ethics review of health-related research with human participants. Geneva: World Health Organization; 2011. ISBN:9789241502948.

10. World Health Organization. WHO tool for benchmarking ethics oversight of health-related research involving human participants. Geneva: World Health Organization; 2023.

11. World Health Organization. WHO guidance on the ethics of health research priority setting. Geneva: World Health Organization; 2025.

12. Central Council for Research in Homoeopathy. Good Clinical Practice Guidelines for Clinical Trials in Homoeopathy. New Delhi: Ministry of AYUSH; 2021.

13. Brien SB, Harrison H, Daniels J, Lewith G. Monitoring improvement in health during homeopathic intervention. Development of an assessment tool based on Hering's Law of Cure: the Hering's Law Assessment Tool (HELAT). Homeopathy. 2012;101(1):28-37. doi:10.1016/j.homp.2011.10.002.

14. Indian Council of Medical Research. ICMR Policy on Research Integrity and Publication Ethics (RIPE). New Delhi: Indian Council of Medical Research; 2019.

Downloads

Published

2026-09-21

Issue

Section

Review articles

How to Cite

Ethical Challenges in Conducting Pediatric Homoeopathic Clinical Research: A Narrative Review. (2026). JOURNAL OF ADVANCED HOMOEOPATHIC STUDIES, 2(3), 39-52. https://doi.org/10.67062/jahs.v2.i3.4

Similar Articles

1-10 of 11

You may also start an advanced similarity search for this article.